Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 AUD | -4.74% | -2.29% | -11.17% |
19/03 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
18/03 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.17% | 111M | |
+8.88% | 219B | |
+8.68% | 185B | |
+14.25% | 135B | |
+28.18% | 107B | |
+14.65% | 51.28B | |
+4.48% | 51.01B | |
+4.39% | 41.85B | |
+7.00% | 37.02B | |
+26.06% | 31.27B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- US FDA Confirms Receipt of Cyclopharm's Response Submission for Inhalable Imaging Agent